Fusilev Trademark Details

Fusilev was registered on Tuesday, August 11, 2009 and is currently owned by Spectrum Pharmaceuticals, Inc. under the registration number 3667433 . This mark is alive with a status of Section 8 & 15-Accepted and Acknowledged. The last case file activity for this mark occured 8 years ago on Friday, August 28, 2015, according to the United State Patent & Trademark Office
Word Mark Fusilev
Status Alive Registered 702 — Section 8 & 15-Accepted and Acknowledged

Current Owner

Spectrum Pharmaceuticals, Inc. of Irvine, CA

View all trademarks for Spectrum Pharmaceuticals, Inc.
Other Trademarks for Spectrum Pharmaceuticals, Inc.
Serial Number 77415998
Registration Number 3667433
Status Date Friday, August 28, 2015
Filing Date Friday, August 28, 2015
Registration Date Tuesday, August 11, 2009
Attorney Susan E. Hollander

Correspondent

Susan E. Hollander
K&L GATES LLP
4 Embarcadero Center, Suite 1200
San Francisco CA 94111

Case File Statements

Goods & Services Pharmaceutical preparation for the treatment of folic deficiency, methotrexate rescue, impaired methotrexate elimination, inadvertent overdosage of folic acid antagonists, osteosarcoma, and colorectal indications
Translation of Words in Mark The wording "FUSILEV" has no meaning in a foreign language.

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Wednesday, March 12, 2008
First Use Anywhere Friday, August 15, 2008
First Use In Commerce Friday, August 15, 2008
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.